Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional profiling of macrophages in situ in metastatic melanoma reveals localization-dependent phenotypes and function. | Cell Rep Med | 2022 | 35584631 | PubTator, text mining | PubMed |
| A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models. | J Immunother Cancer | 2022 | 35580926 | PubTator, text mining | PubMed |
| Regulatory mechanism of miR-20a-5p expression in Cancer. | Cell Death Discov | 2022 | 35577802 | PubTator, text mining | PubMed |
| Optical Control of Adenosine A3 Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis? | Front Immunol | 2022 | 35572558 | PubTator, text mining | PubMed |
| Pyroptosis-Related Gene Signature and Expression Patterns in the Deterioration of Atherosclerosis. | Dis Markers | 2022 | 35571620 | PubTator, text mining | PubMed |
| CD73/Adenosine Pathway Involvement in the Interaction of Non-Small Cell Lung Cancer Stem Cells and Bone Cells in the Pre-Metastatic Niche. | Int J Mol Sci | 2022 | 35563517 | PubTator, text mining | PubMed |
| The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? | Int J Mol Sci | 2022 | 35562894 | PubTator, text mining | PubMed |
| Off-targetP ML: an open source machine learning framework for off-target panel safety assessment of small molecules. | J Cheminform | 2022 | 35525988 | PubTator, text mining | PubMed |
| Prediction and Identification of GPCRs Targeting for Drug Repurposing in Osteosarcoma. | Front Oncol | 2022 | 35463319 | PubTator, text mining | PubMed |
| A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? | Molecules | 2022 | 35458588 | PubTator, text mining | PubMed |
| 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives. | Pharmaceuticals (Basel) | 2022 | 35455475 | PubTator, text mining | PubMed |
| The Purinergic Landscape of Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 35454832 | PubTator, text mining | PubMed |
| Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species. | ACS Med Chem Lett | 2022 | 35450351 | PubTator, text mining | PubMed |
| Candidate pathways for retina to scleral signaling in refractive eye growth. | Exp Eye Res | 2022 | 35447101 | PubTator, text mining | PubMed |
| Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives. | J Enzyme Inhib Med Chem | 2022 | 35438580 | PubTator, text mining | PubMed |
| Development of Bicyclo[3.1.0]hexane-Based A3 Receptor Ligands: Closing the Gaps in the Structure-Affinity Relationships. | Molecules | 2022 | 35408685 | PubTator, text mining | PubMed |
| Anti-Hair Loss Effect of Adenosine Is Exerted by cAMP Mediated Wnt/β-Catenin Pathway Stimulation via Modulation of Gsk3β Activity in Cultured Human Dermal Papilla Cells. | Molecules | 2022 | 35408582 | PubTator, text mining | PubMed |
| Molecular Simulations and Drug Discovery of Adenosine Receptors. | Molecules | 2022 | 35408454 | PubTator, text mining | PubMed |
| Transcription Profile and Pathway Analysis of the Endocannabinoid Receptor Inverse Agonist AM630 in the Core and Infiltrative Boundary of Human Glioblastoma Cells. | Molecules | 2022 | 35408449 | PubTator, text mining | PubMed |
| Sevoflurane Dampens Acute Pulmonary Inflammation via the Adenosine Receptor A2B and Heme Oxygenase-1. | Cells | 2022 | 35406657 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers?page=17